Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2013; 15 (6): 735-741

《亚洲男性学杂志》 2013; 15 (6): 735–741

基因miR-205表达下调抑制前列腺肿瘤生长
Ning Wang, Qi Li, Ning-Han Feng, Gong Cheng, Zhao-Long Guan, Yang Wang, Chao Qin, Chang-Jun Yin and Li-Xin Hua(中国)

本文旨在研究抑癌基因has-miR-205在前列腺癌中的分子和功能机制。通过对早期和晚期前列腺癌组织进行miRNAs表达的基因芯片分析,从中选出异常表达的miR-205进行实时定量PCR分析,并对其在前列腺癌中的功能和靶基因c-SRC及其下游FAK/ERK1/2通路进行分析。结果发现miR-205在晚期前列腺癌中呈现低表达,其表达量与临床病理分期和总PSA及游离PSA呈负关联。体外功能试验分析显示高表达miR-205或是敲除c-SRC基因的表达可以抑制前列腺癌细胞的增殖与转移。裸鼠体内实验分析高表达miR-205可以抑制前列腺癌肿瘤形成。通过荧光素酶报告基因和Western blotting分析证实c-SRC是miR-205的靶基因,高表达的miR-205抑制c-SRC及下游通路FAK, p-FAK, ERK1/2 和p-ERK1/2的蛋白表达。抑癌基因miR-205在前列腺癌中低表达,并且通过靶基因c-SRC来抑制前列腺癌细胞的增殖和转移。

关键词: c-SRC,miR-205,前列腺癌,肿瘤生长

此摘要文献来源:
Ning Wang, Qi Li, Ning-Han Feng, Gong Cheng, Zhao-Long Guan et al. HuamiR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. Asian J Androl 2013;15: 735–741.

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.